An international research team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy, unlocking new pathways to treatment.
This content was published on
2 minutes
UniB/jdp
Português
pt
Pesquisadores na Suíça descobrem chave para resistência a tratamento do câncer de próstata
The findings published in Nature CommunicationsExternal link shed light on “epigenetic” changes in cells that cause some aggressive forms of prostate cancer to become resistant to hormone therapy. These changes do not involve alterations of the DNA genetic code but often regulate gene activity and expression.
Prostate cancer is the second most common cancer and the fifth cause of cancer-related death in men worldwide. Most localized prostate cancer can be treated with surgery and radiotherapy, but metastatic cancer typically relies on hormone therapies. However, resistance to this therapy often develops.
To date, most studies on treatment resistance have focused on changes in the DNA sequence in cancer cells – genetic mutation. However, cancers can also become resistant to treatment through changes in cell identity. This “linear plasticity” helps them evade treatment.
As studies show that changes in the DNA are not sufficient to cause such a transformation in cell identity, a research team led Dr. Mark Rubin at the Bern Center for Precision Medicine sought to understand what other changes occur in cancer cells could enable this identity shift.
The research team found “epigenetic” changes could influence the way a cell uses the information contained in its DNA.
“Cancer cells can hijack this machinery to favor their growth over the surrounding normal cells,” explained Rubin in a statementExternal link.
The research team focused on one epigenetic regulator, called the SWI/SNF complex, which remodels a cell’s DNA and can cause the cells to grow and change. Dr. Rubin’s team observed that several prostate cancer cell lines are dependent on the SWI/SNF complex for their growth.
The Bern Center for Precision Medicine, a joint initiative between University of Bern and Insel Hospital, was launched in 2019 and explores precision medicine, especially in areas where there are no standard of care options.
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
Opinion
More
Precision Medicine: A game changer for brain and mental health
This content was published on
Cancer patients benefit from precision medicine, but we must invest in a personalised approach to treating neurological disease such as Alzheimer’s.
The pharma holy grail: drugs for you, designed by you
This content was published on
In the age of sensors, wearables, and artificial intelligence (AI), almost everything can be customised for the individual.
Swiss cancer research yields breast-saving fat, better detection
This content was published on
The incidence of breast cancer in Switzerland is high, but research offers hope – especially the finding that cancer cells can be converted into fat.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.